This is a double-blind, placebo controlled, multicenter study that evaluates the performance and safety of the Favipiravir combined with supportive care for adult patients with COVID-19-moderate type.
This study evaluates treatment with Favipiravir combined with supportive care for adult patients with COVID-19-moderate type.